{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-098123","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2026-09-08T21:25:14+00:00","discovered_at":"2026-09-08T21:26:00.609914+00:00","generated_at":"2026-09-08T21:26:11.040460+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Estrella Immunopharma receives Nasdaq delisting notice for MVLS below $35M","bullets":["Nasdaq letter Sept 1, 2026: MVLS below $35M for 30 straight business days (Jul 21-Aug 31, 2026).","Also fails alternative standards: stockholders' equity <$2.5M, net income <$500k.","Compliance period until Mar 1, 2027; must hit $35M MVLS for 10 consecutive days.","Common stock continues trading on Nasdaq Capital Market under ESLA; no immediate effect.","Company to monitor MVLS and evaluate options; no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-098123","json":"https://secwatch.observer/filing/0001213900-26-098123.json","markdown":"https://secwatch.observer/filing/0001213900-26-098123.md","text":"https://secwatch.observer/filing/0001213900-26-098123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390026098123/0001213900-26-098123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390026098123/ea030490301-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T21:26:11.040460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}